Abstract
This section provides summaries of the epidemiology, phenomenology, nosology, and the suspected biological substrates of the depressive disorders. It particularly emphasizes the historical evolution of the pertinent diagnostic constructs and the prognostic import both of the various diagnostic groupings and of the individual symptoms and symptom clusters.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
aan het Rot M, Collins KA, Murrough JW, Perez AM, Reich DL, Charney DS, Mathew SJ (2010) Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry 67(2):139–145. https://doi.org/10.1016/j.biopsych.2009.08.038
Akhondzadeh S, Jafari S, Raisi F, Nasehi AA, Ghoreishi A, Salehi B, Mohebbi-Rasa S, Raznahan M, Kamalipour A (2009) Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial. Depress Anxiety 26(7):607–611. https://doi.org/10.1002/da.20589
Andreasen NC, Grove WM, Coryell WH, Endicott J, Clayton PJ (1988) Bipolar versus unipolar and primary versus secondary affective disorder: which diagnosis takes precedence? J Affect Disord 15(1):69–80
Angst J (1966) On the etiology and nosology of endogenous depressive psychoses. A genetic, sociologic and clinical study. Monogr Gesamtgeb Neurol Psychiatr 112:1–118
Angst J, Gamma A, Benazzi F, Ajdacic V, Eich D, Rössler W (2003) Toward a re-definition of subthreshold bipolarity: epidemiology and proposed criteria for bipolar-II, minor bipolar disorders and hypomania. J Affect Disord 73(1):133–146
Angst J, Angst F, Gerber-Werder R, Gamma A (2005) Suicide in 406 mood-disorder patients with and without long-term medication: a 40 to 44 years’ follow-up. Arch Suicide Res 9(3):279–300. https://doi.org/10.1080/13811110590929488
Angst J, Gamma A, Rossler W, Ajdacic V, Klein DN (2009) Long-term depression versus episodic major depression: results from the prospective Zurich study of a community sample. J Affect Disord 115(1–2):112–121. https://doi.org/10.1016/j.jad.2008.09.023
Arsenault-Lapierre G, Kim C, Turecki G (2004) Psychiatric diagnoses in 3275 suicides: a meta-analysis. BMC Psychiatry 4(1):37
Asberg M, Thoren P, Traskman L, Bertilsson L, Ringberger V (1976) “Serotonin depression” – a biochemical subgroup within the affective disorders? Science 191(4226):478–480
Ballard ED, Ionescu DF, Vande Voort JL, Niciu MJ, Richards EM, Luckenbaugh DA, Brutsche NE, Ameli R, Furey ML, Zarate CA Jr (2014) Improvement in suicidal ideation after ketamine infusion: relationship to reductions in depression and anxiety. J Psychiatr Res 58:161–166. https://doi.org/10.1016/j.jpsychires.2014.07.027
Barnes MP, Saunders M, Walls TJ, Saunders I, Kirk CA (1986) The syndrome of Karl Ludwig Kahlbaum. J Neurol Neurosurg Psychiatry 49(9):991–996
Barnhofer T, Brennan K, Crane C, Duggan D, Williams JM (2014) A comparison of vulnerability factors in patients with persistent and remitting lifetime symptom course of depression. J Affect Disord 152–154:155–161. https://doi.org/10.1016/j.jad.2013.09.001
Basterzi AD, Aydemir C, Kisa C, Aksaray S, Tuzer V, Yazici K, Goka E (2005) IL-6 levels decrease with SSRI treatment in patients with major depression. Hum Psychopharmacol 20(7):473–476. https://doi.org/10.1002/hup.717
Baumeister D, Russell A, Pariante CM, Mondelli V (2014) Inflammatory biomarker profiles of mental disorders and their relation to clinical, social and lifestyle factors. Soc Psychiatry Psychiatr Epidemiol 49(6):841–849. https://doi.org/10.1007/s00127-014-0887-z
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4:561–571
Benazzi F (1999) Bipolar II versus unipolar chronic depression: a 312-case study. Compr Psychiatry 40(6):418–421
Benazzi F (2001) Atypical depression with hypomanic symptoms. J Affect Disord 65(2):179–183
Benazzi F (2002) Can only reversed vegetative symptoms define atypical depression? Eur Arch Psychiatry Clin Neurosci 252(6):288–293. https://doi.org/10.1007/s00406-002-0395-0
Benazzi F, Koukopoulos A, Akiskal HS (2004) Toward a validation of a new definition of agitated depression as a bipolar mixed state (mixed depression). Eur Psychiatry 19(2):85–90. https://doi.org/10.1016/j.eurpsy.2003.09.008
Berardi D, Dell’Atti M, Amore M, De Ronchi D, Ferrari G (2002) Clinical risk factors for neuroleptic malignant syndrome. Hum Psychopharmacol Clin Exp 17(2):99–102
Berman RM, Narasimhan M, Miller HL, Anand A, Cappiello A, Oren DA, Heninger GR, Charney DS (1999) Transient depressive relapse induced by catecholamine depletion: potential phenotypic vulnerability marker? Arch Gen Psychiatry 56(5):395–403
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS, Krystal JH (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47(4):351–354
Bernert RA, Kim JS, Iwata NG, Perlis ML (2015) Sleep disturbances as an evidence-based suicide risk factor. Curr Psychiatry Rep 17(3):554. https://doi.org/10.1007/s11920-015-0554-4
Bhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews PM, Cowen PJ (2004) Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 161(2):368–370. https://doi.org/10.1176/appi.ajp.161.2.368
Biederman J, Wozniak J, Tarko L, Serra G, Hernandez M, McDermott K, Woodsworth KY, Uchida M, Faraone SV (2014) Re-examining the risk for switch from unipolar to bipolar major depressive disorder in youth with ADHD: a long term prospective longitudinal controlled study. J Affect Disord 152–154:347–351. https://doi.org/10.1016/j.jad.2013.09.036
Black DW, Bell S, Hulbert J, Nasrallah A (1988) The importance of axis II in patients with major depression. A controlled study. J Affect Disord 14(2):115–122
Blanco C, Okuda M, Markowitz JC, Liu SM, Grant BF, Hasin DS (2010) The epidemiology of chronic major depressive disorder and dysthymic disorder: results from the National Epidemiologic Survey on alcohol and related conditions. J Clin Psychiatry 71(12):1645–1656. https://doi.org/10.4088/JCP.09m05663gry
Bond DJ, Andreazza AC, Hughes J, Dhanoa T, Torres IJ, Kozicky JM, Young LT, Lam RW, Yatham LN (2016) Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder. Psychoneuroendocrinology 65:76–83. https://doi.org/10.1016/j.psyneuen.2015.12.012
Bostwick JM, Pankratz VS (2000) Affective disorders and suicide risk: a reexamination. Am J Psychiatry 157(12):1925–1932. https://doi.org/10.1176/appi.ajp.157.12.1925
Breslau N, Davis GC (1985) Refining DSM-III criteria in major depression. An assessment of the descriptive validity of criterion symptoms. J Affect Disord 9(3):199–206
Bromet EJ, Kotov R, Fochtmann LJ, Carlson GA, Tanenberg-Karant M, Ruggero C, Chang SW (2011) Diagnostic shifts during the decade following first admission for psychosis. Am J Psychiatry 168(11):1186–1194. https://doi.org/10.1176/appi.ajp.2011.11010048
Brown WA (2007) Treatment response in melancholia. Acta Psychiatr Scand Suppl 433:125–129. https://doi.org/10.1111/j.1600-0447.2007.00970.x
Brown ES, Park J, Marx CE, Hynan LS, Gardner C, Davila D, Nakamura A, Sunderajan P, Lo A, Holmes T (2014) A randomized, double-blind, placebo-controlled trial of pregnenolone for bipolar depression. Neuropsychopharmacology 39(12):2867–2873. https://doi.org/10.1038/npp.2014.138
Brunoni AR, Machado-Vieira R, Sampaio-Junior B, Vieira EL, Valiengo L, Bensenor IM, Lotufo PA, Carvalho AF, Cho HJ, Gattaz WF, Teixeira AL (2015) Plasma levels of soluble TNF receptors 1 and 2 after tDCS and sertraline treatment in major depression: results from the SELECT-TDCS trial. J Affect Disord 185:209–213. https://doi.org/10.1016/j.jad.2015.07.006
Buchan H, Johnstone E, McPherson K, Palmer RL, Crow TJ, Brandon S (1992) Who benefits from electroconvulsive therapy? Combined results of the Leicester and Northwick Park trials. Br J Psychiatry 160:355–359
Capuron L, Ravaud A, Gualde N, Bosmans E, Dantzer R, Maes M, Neveu PJ (2001) Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology 26(8):797–808
Capuron L, Gumnick JF, Musselman DL, Lawson DH, Reemsnyder A, Nemeroff CB, Miller AH (2002) Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology 26(5):643–652. https://doi.org/10.1016/S0893-133X(01)00407-9
Capuron L, Su S, Miller AH, Bremner JD, Goldberg J, Vogt GJ, Maisano C, Jones L, Murrah NV, Vaccarino V (2008) Depressive symptoms and metabolic syndrome: is inflammation the underlying link? Biol Psychiatry 64(10):896–900. https://doi.org/10.1016/j.biopsych.2008.05.019
Carroll BJ, Feinberg M, Greden JF, Tarika J, Albala AA, Haskett RF, James NM, Kronfol Z, Lohr N, Steiner M, de Vigne JP, Young E (1981) A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry 38(1):15–22
Cattaneo A, Macchi F, Plazzotta G, Veronica B, Bocchio-Chiavetto L, Riva MA, Pariante CM (2015) Inflammation and neuronal plasticity: a link between childhood trauma and depression pathogenesis. Front Cell Neurosci 9:40. https://doi.org/10.3389/fncel.2015.00040
Charney DS, Nelson JC (1981) Delusional and nondelusional unipolar depression: further evidence for distinct subtypes. Am J Psychiatry 138(3):328–333. https://doi.org/10.1176/ajp.138.3.328
Charney DS, Nelson JC, Quinlan DM (1981) Personality traits and disorder in depression. Am J Psychiatry 138(12):1601–1604. https://doi.org/10.1176/ajp.138.12.1601
Cohen LS, Altshuler LL, Harlow BL, Nonacs R, Newport DJ, Viguera AC, Suri R, Burt VK, Hendrick V, Reminick AM, Loughead A, Vitonis AF, Stowe ZN (2006) Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295(5):499–507. https://doi.org/10.1001/jama.295.5.499
Corruble E, Ginestet D, Guelfi JD (1996) Comorbidity of personality disorders and unipolar major depression: a review. J Affect Disord 37(2–3):157–170
Coryell W, Young EA (2005) Clinical predictors of suicide in primary major depressive disorder. J Clin Psychiatry 66(4):412–417
Coryell WH, Zimmerman M (1989) HPA axis hyperactivity and recovery from functional psychoses. Am J Psychiatry 146(4):473–477. https://doi.org/10.1176/ajp.146.4.473
Coryell W, Pfohl B, Zimmerman M (1984) The clinical and neuroendocrine features of psychotic depression. J Nerv Ment Dis 172(9):521–528
Coryell W, Endicott J, Keller M, Andreasen NC (1985) Phenomenology and family history in DSM-III psychotic depression. J Affect Disord 9(1):13–18
Coryell W, Endicott J, Keller M (1990) Outcome of patients with chronic affective disorder: a five-year follow-up. Am J Psychiatry 147(12):1627–1633. https://doi.org/10.1176/ajp.147.12.1627
Coryell W, Endicott J, Winokur G (1992) Anxiety syndromes as epiphenomena of primary major depression: outcome and familial psychopathology. Am J Psychiatry 149(1):100–107. https://doi.org/10.1176/ajp.149.1.100
Coryell W, Winokur G, Maser JD, Akiskal HS, Keller MB, Endicott J (1994a) Recurrently situational (reactive) depression: a study of course, phenomenology and familial psychopathology. J Affect Disord 31(3):203–210
Coryell W, Winokur G, Shea T, Maser JD, Endicott J, Akiskal HS (1994b) The long-term stability of depressive subtypes. Am J Psychiatry 151(2):199–204
Coryell W, Leon A, Winokur G, Endicott J, Keller M, Akiskal H, Solomon D (1996) Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry 153(4):483–489. https://doi.org/10.1176/ajp.153.4.483
Coryell W, Solomon DA, Fiedorowicz JG, Endicott J, Schettler PJ, Judd LL (2009) Anxiety and outcome in bipolar disorder. Am J Psychiatry 166(11):1238–1243. https://doi.org/10.1176/appi.ajp.2009.09020218
Coryell W, Fiedorowicz JG, Solomon D, Leon AC, Rice JP, Keller MB (2012) Effects of anxiety on the long-term course of depressive disorders. Br J Psychiatry 200(3):210–215. https://doi.org/10.1192/bjp.bp.110.081992
Coryell WH, Butcher BD, Burns TL, Dindo LN, Schlechte JA, Calarge CA (2016) Fat distribution and major depressive disorder in late adolescence. J Clin Psychiatry 77(1):84–89. https://doi.org/10.4088/JCP.14m09169
Cross-National Collaborative Group, Wittchen H-U (1992) The changing rate of major depression: cross-national comparisons. JAMA 268(21):3098–3105
Crow TJ, Deakin JFW, Johnstone EC, MacMillan JF, Owens DGC, Lawler P, Frith CD, Stevens M, McPherson K (1984) The Northwick Park ECT trial. Predictors of response to real and simulated ECT. Clinical Research Centre, Division of Psychiatry. Br J Psychiatry 144:227–237
Cuijpers P, Weitz E, Lamers F, Penninx BW, Twisk J, DeRubeis RJ, Dimidjian S, Dunlop BW, Jarrett RB, Segal ZV (2017) Melancholic and atypical depression as predictor and moderator of outcome in cognitive behavior therapy and pharmacotherapy for adult depression. Depress Anxiety 34(3):246–256
Curtin SC, Warner M, Hedegaard H (2016) Increase in suicide in the United States, 1999–2014. NCHS Data Brief 241:1–8
Danese A, Pariante CM, Caspi A, Taylor A, Poulton R (2007) Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci U S A 104(4):1319–1324. https://doi.org/10.1073/pnas.0610362104
Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47(5):411–418
Deligiannidis KM, Kroll-Desrosiers AR, Mo S, Nguyen HP, Svenson A, Jaitly N, Hall JE, Barton BA, Rothschild AJ, Shaffer SA (2016) Peripartum neuroactive steroid and gamma-aminobutyric acid profiles in women at-risk for postpartum depression. Psychoneuroendocrinology 70:98–107. https://doi.org/10.1016/j.psyneuen.2016.05.010
Di Florio A, Forty L, Gordon-Smith K, Heron J, Jones L, Craddock N, Jones I (2013) Perinatal episodes across the mood disorder spectrum. JAMA Psychiat 70(2):168–175. https://doi.org/10.1001/jamapsychiatry.2013.279
Dinan T, Siggins L, Scully P, O’Brien S, Ross P, Stanton C (2009) Investigating the inflammatory phenotype of major depression: focus on cytokines and polyunsaturated fatty acids. J Psychiatr Res 43(4):471–476. https://doi.org/10.1016/j.jpsychires.2008.06.003
Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctot KL (2010) A meta-analysis of cytokines in major depression. Biol Psychiatry 67(5):446–457. https://doi.org/10.1016/j.biopsych.2009.09.033
Ducasse D, Loas G, Dassa D, Gramaglia C, Zeppegno P, Guillaume S, Olie E, Courtet P (2017) Anhedonia is associated with suicidal ideation independently of depression: a meta-analysis. Depress Anxiety. https://doi.org/10.1002/da.22709
Eller T, Vasar V, Shlik J, Maron E (2008) Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 32(2):445–450. https://doi.org/10.1016/j.pnpbp.2007.09.015
Fattori A, Neri L, Bellomo A, Vaggi M, Mencacci C, Group IS (2017) Depression severity and concentration difficulties are independently associated with HRQOL in patients with unipolar depressive disorders. Qual Life Res 26(9):2459–2469. https://doi.org/10.1007/s11136-017-1595-4
Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH (2008) Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry 165(3):342–351. https://doi.org/10.1176/appi.ajp.2007.06111868
Fava M, Ball S, Nelson JC, Sparks J, Konechnik T, Classi P, Dube S, Thase ME (2014) Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depress Anxiety 31(3):250–257. https://doi.org/10.1002/da.22199
Feighner JP, Robins E, Guze SB, Woodruff RA Jr, Winokur G, Munoz R (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26(1):57–63
Feske U, Frank E, Kupfer DJ, Shear MK, Weaver E (1998) Anxiety as a predictor of response to interpersonal psychotherapy for recurrent major depression: an exploratory investigation. Depress Anxiety 8(4):135–141
Feske U, Mulsant BH, Pilkonis PA, Soloff P, Dolata D, Sackeim HA, Haskett RF (2004) Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder. Am J Psychiatry 161(11):2073–2080. https://doi.org/10.1176/appi.ajp.161.11.2073
Fiedorowicz JG, He J, Merikangas KR (2011a) The association between mood and anxiety disorders with vascular diseases and risk factors in a nationally representative sample. J Psychosom Res 70(2):145–154. https://doi.org/10.1016/j.jpsychores.2010.07.010
Fiedorowicz JG, Endicott J, Leon AC, Solomon DA, Keller MB, Coryell WH (2011b) Subthreshold hypomanic symptoms in progression from unipolar major depression to bipolar disorder. Am J Psychiatry 168(1):40–48. https://doi.org/10.1176/appi.ajp.2010.10030328
Fisch RZ (1987) Masked depression: its interrelations with somatization, hypochondriasis and conversion. Int J Psychiatry Med 17(4):367–379
Fisch RZ, Tadmor OP, Dankner R, Diamant YZ (1997) Postnatal depression: a prospective study of its prevalence, incidence and psychosocial determinants in an Israeli sample. J Obstet Gynaecol Res 23(6):547–554
Fond G, Hamdani N, Kapczinski F, Boukouaci W, Drancourt N, Dargel A, Oliveira J, Le Guen E, Marlinge E, Tamouza R, Leboyer M (2014) Effectiveness and tolerance of anti-inflammatory drugs’ add-on therapy in major mental disorders: a systematic qualitative review. Acta Psychiatr Scand 129(3):163–179. https://doi.org/10.1111/acps.12211
Forty L, Jones L, Macgregor S, Caesar S, Cooper C, Hough A, Dean L, Dave S, Farmer A, McGuffin P, Brewster S, Craddock N, Jones I (2006) Familiality of postpartum depression in unipolar disorder: results of a family study. Am J Psychiatry 163(9):1549–1553. https://doi.org/10.1176/ajp.2006.163.9.1549
Francis A, Divadeenam KM, Bush G, Petrides G (1997) Consistency of symptoms in recurrent catatonia. Compr Psychiatry 38(1):56–60
Garvey MJ, Tollefson GD, Tuason VB (1986) Is chronic primary major depression a distinct depression subtype? Compr Psychiatry 27(5):446–448
Geoffroy PA, Hoertel N, Etain B, Bellivier F, Delorme R, Limosin F, Peyre H (2018) Insomnia and hypersomnia in major depressive episode: prevalence, sociodemographic characteristics and psychiatric comorbidity in a population-based study. J Affect Disord 226:132–141. https://doi.org/10.1016/j.jad.2017.09.032
Gerner RH, Hare TA (1981) CSF GABA in normal subjects and patients with depression, schizophrenia, mania, and anorexia nervosa. Am J Psychiatry 138(8):1098–1101. https://doi.org/10.1176/ajp.138.8.1098
Ghasemi M, Kazemi MH, Yoosefi A, Ghasemi A, Paragomi P, Amini H, Afzali MH (2014) Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder. Psychiatry Res 215(2):355–361. https://doi.org/10.1016/j.psychres.2013.12.008
Ghatavi K, Nicolson R, MacDonald C, Osher S, Levitt A (2002) Defining guilt in depression: a comparison of subjects with major depression, chronic medical illness and healthy controls. J Affect Disord 68(2–3):307–315
Gibbons RD, Davis JM (1986) Consistent evidence for a biological subtype of depression characterized by low CSF monoamine levels. Acta Psychiatr Scand 74(1):8–12
Gilmer WS, Trivedi MH, Rush AJ, Wisniewski SR, Luther J, Howland RH, Yohanna D, Khan A, Alpert J (2005) Factors associated with chronic depressive episodes: a preliminary report from the STAR-D project. Acta Psychiatr Scand 112(6):425–433. https://doi.org/10.1111/j.1600-0447.2005.00633.x
Giuffra LA, Risch N (1994) Diminished recall and the cohort effect of major depression: a simulation study. Psychol Med 24(2):375–383
Glassman AH, Roose SP (1981) Delusional depression. A distinct clinical entity? Arch Gen Psychiatry 38(4):424–427
Glassman AH, Kantor SJ, Shostak M (1975) Depression, delusions, and drug response. Am J Psychiatry 132(7):716–719. https://doi.org/10.1176/ajp.132.7.716
Goes FS, McCusker MG, Bienvenu OJ, Mackinnon DF, Mondimore FM, Schweizer B, National Institute of Mental Health Genetics Initiative Bipolar Disorder C, Depaulo JR, Potash JB (2012) Co-morbid anxiety disorders in bipolar disorder and major depression: familial aggregation and clinical characteristics of co-morbid panic disorder, social phobia, specific phobia and obsessive-compulsive disorder. Psychol Med 42(7):1449–1459. https://doi.org/10.1017/S0033291711002637
Gonzales LR, Lewinsohn PM, Clarke GN (1985) Longitudinal follow-up of unipolar depressives: an investigation of predictors of relapse. J Consult Clin Psychol 53(4):461–469
Gotlib IH, Whiffen VE, Mount JH, Milne K, Cordy NI (1989) Prevalence rates and demographic characteristics associated with depression in pregnancy and the postpartum. J Consult Clin Psychol 57(2):269–274
Greenberg PE, Fournier AA, Sisitsky T, Pike CT, Kessler RC (2015) The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J Clin Psychiatry 76(2):155–162. https://doi.org/10.4088/JCP.14m09298
Grunebaum MF, Galfalvy HC, Choo TH, Keilp JG, Moitra VK, Parris MS, Marver JE, Burke AK, Milak MS, Sublette ME, Oquendo MA, Mann JJ (2018) Ketamine for rapid reduction of suicidal thoughts in major depression: a midazolam-controlled randomized clinical trial. Am J Psychiatry 175(4):327–335. https://doi.org/10.1176/appi.ajp.2017.17060647
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23(1):56
Harris TH (1957) Depression induced by Rauwolfia compounds. Am J Psychiatry 113(10):950. https://doi.org/10.1176/ajp.113.10.950
Hernandez ME, Mendieta D, Martinez-Fong D, Loria F, Moreno J, Estrada I, Bojalil R, Pavon L (2008) Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder. Eur Neuropsychopharmacol 18(12):917–924. https://doi.org/10.1016/j.euroneuro.2008.08.001
Hiles SA, Baker AL, de Malmanche T, Attia J (2012) Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis. Psychol Med 42(10):2015–2026. https://doi.org/10.1017/S0033291712000128
Hirschfeld RM, Koslow SH, Kupfer DJ (1983) The clinical utility of the dexamethasone suppression test in psychiatry. Summary of a National Institute of Mental Health workshop. JAMA 250(16):2172–2174
Hollon SD, Shelton RC, Wisniewski S, Warden D, Biggs MM, Friedman ES, Husain M, Kupfer DJ, Nierenberg AA, Petersen TJ, Shores-Wilson K, Rush AJ (2006) Presenting characteristics of depressed outpatients as a function of recurrence: preliminary findings from the STAR*D clinical trial. J Psychiatr Res 40(1):59–69. https://doi.org/10.1016/j.jpsychires.2005.07.008
Howren MB, Lamkin DM, Suls J (2009) Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 71(2):171–186. https://doi.org/10.1097/PSY.0b013e3181907c1b
Jaso BA, Niciu MJ, Iadarola ND, Lally N, Richards EM, Park M, Ballard ED, Nugent AC, Machado-Vieira R, Zarate CA (2017) Therapeutic modulation of glutamate receptors in major depressive disorder. Curr Neuropharmacol 15(1):57–70
Jones I, Craddock N (2001) Familiality of the puerperal trigger in bipolar disorder: results of a family study. Am J Psychiatry 158(6):913–917. https://doi.org/10.1176/appi.ajp.158.6.913
Judd LL, Akiskal HS, Maser JD, Zeller PJ, Endicott J, Coryell W, Paulus MP, Kunovac JL, Leon AC, Mueller TI, Rice JA, Keller MB (1998) Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. J Affect Disord 50(2–3):97–108
Judd LL, Paulus MJ, Schettler PJ, Akiskal HS, Endicott J, Leon AC, Maser JD, Mueller T, Solomon DA, Keller MB (2000) Does incomplete recovery from first lifetime major depressive episode herald a chronic course of illness? Am J Psychiatry 157(9):1501–1504. https://doi.org/10.1176/appi.ajp.157.9.1501
Judd LL, Schettler PJ, Rush AJ, Coryell WH, Fiedorowicz JG, Solomon DA (2016) A new empirical definition of major depressive episode recovery and its positive impact on future course of illness. J Clin Psychiatry 77(8):1065–1073. https://doi.org/10.4088/JCP.15m09918
Juruena MF, Bocharova M, Agustini B, Young AH (2017) Atypical depression and non-atypical depression: is HPA axis function a biomarker? A systematic review. J Affect Disord 233:45–67. https://doi.org/10.1016/j.jad.2017.09.052
Kanes S, Colquhoun H, Gunduz-Bruce H, Raines S, Arnold R, Schacterle A, Doherty J, Epperson CN, Deligiannidis KM, Riesenberg R, Hoffmann E, Rubinow D, Jonas J, Paul S, Meltzer-Brody S (2017) Brexanolone (SAGE-547 injection) in post-partum depression: a randomised controlled trial. Lancet 390(10093):480–489. https://doi.org/10.1016/S0140-6736(17)31264-3
Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM (2018) Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry 23(2):335–343. https://doi.org/10.1038/mp.2016.167
Kasa K, Otsuki S, Yamamoto M, Sato M, Kuroda H, Ogawa N (1982) Cerebrospinal fluid gamma-aminobutyric acid and homovanillic acid in depressive disorders. Biol Psychiatry 17(8):877–883
Keller MB, Lavori PW, Endicott J, Coryell W, Klerman GL (1983a) “Double depression”: two-year follow-up. Am J Psychiatry 140(6):689–694. https://doi.org/10.1176/ajp.140.6.689
Keller MB, Lavori PW, Lewis CE, Klerman GL (1983b) Predictors of relapse in major depressive disorder. JAMA 250(24):3299–3304
Kendler KS (1995) Is seeking treatment for depression predicted by a history of depression in relatives? Implications for family studies of affective disorder. Psychol Med 25(4):807–814
Kendler KS, Karkowski-Shuman L (1997) Stressful life events and genetic liability to major depression: genetic control of exposure to the environment? Psychol Med 27(3):539–547
Kendler KS, Eaves LJ, Walters EE, Neale MC, Heath AC, Kessler RC (1996) The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry 53(5):391–399
Kendler KS, Kuhn J, Prescott CA (2004) The interrelationship of neuroticism, sex, and stressful life events in the prediction of episodes of major depression. Am J Psychiatry 161(4):631–636. https://doi.org/10.1176/appi.ajp.161.4.631
Kendler KS, Myers J, Zisook S (2008) Does bereavement-related major depression differ from major depression associated with other stressful life events? Am J Psychiatry 165(11):1449–1455. https://doi.org/10.1176/appi.ajp.2008.07111757
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen HU, Kendler KS (1994) Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 51(1):8–19
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS, National Comorbidity Survey R (2003) The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289(23):3095–3105. https://doi.org/10.1001/jama.289.23.3095
Kessler RC, Berglund P, Borges G, Nock M, Wang PS (2005) Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA 293(20):2487–2495. https://doi.org/10.1001/jama.293.20.2487
Kishimoto T, Chawla JM, Hagi K, Zarate CA, Kane JM, Bauer M, Correll CU (2016) Single-dose infusion ketamine and non-ketamine N-methyl-d-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories. Psychol Med 46(7):1459–1472. https://doi.org/10.1017/S0033291716000064
Klein DN, Taylor EB, Harding K, Dickstein S (1988) Double depression and episodic major depression: demographic, clinical, familial, personality, and socioenvironmental characteristics and short-term outcome. Am J Psychiatry 145(10):1226–1231. https://doi.org/10.1176/ajp.145.10.1226
Klein DN, Schwartz JE, Rose S, Leader JB (2000) Five-year course and outcome of dysthymic disorder: a prospective, naturalistic follow-up study. Am J Psychiatry 157(6):931–939. https://doi.org/10.1176/appi.ajp.157.6.931
Klein DN, Shankman SA, Lewinsohn PM, Rohde P, Seeley JR (2004) Family study of chronic depression in a community sample of young adults. Am J Psychiatry 161(4):646–653. https://doi.org/10.1176/appi.ajp.161.4.646
Koukopoulos A, Sani G, Koukopoulos AE, Manfredi G, Pacchiarotti I, Girardi P (2007) Melancholia agitata and mixed depression. Acta Psychiatr Scand Suppl 433:50–57. https://doi.org/10.1111/j.1600-0447.2007.00963.x
Kraepelin E (1921) In: Carlson ET (ed) Manic-depressive insanity and paranoia. Arno Press
Krishna KR, Maniar RC, Harbishettar VS (2011) A comparative study of “idiopathic catatonia” with catatonia in schizophrenia. Asian J Psychiatr 4(2):129–133. https://doi.org/10.1016/j.ajp.2011.04.007
Kroenke K, Spitzer RL, Williams JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16(9):606–613
Krystal JH, Petrakis IL, Mason G, Trevisan L, D’Souza DC (2003) N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability. Pharmacol Ther 99(1):79–94
Lam RW, Michalak EE, Bond DJ, Tam EM, Axler A, Yatham LN (2012) Which depressive symptoms and medication side effects are perceived by patients as interfering most with occupational functioning? Depress Res Treat 2012:630206. https://doi.org/10.1155/2012/630206
Leckman JF, Weissman MM, Prusoff BA, Caruso KA, Merikangas KR, Pauls DL, Kidd KK (1984) Subtypes of depression. Family study perspective. Arch Gen Psychiatry 41(9):833–838
Leonhard K, Korff I, Schulz H (1962) Temperament in families with monopolar and bipolar phasic psychoses. Psychiatr Neurol (Basel) 143:416–434
Lewis AJ (1934) Melancholia: a clinical survey of depressive states. J Ment Sci 80:277–378
Li Z, Qi D, Chen J, Zhang C, Yi Z, Yuan C, Wang Z, Hong W, Yu S, Cui D, Fang Y (2013) Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-alpha) in the Chinese patients with major depressive disorder: a prospective longitudinal study. Psychoneuroendocrinology 38(1):107–114. https://doi.org/10.1016/j.psyneuen.2012.05.005
Luscher B, Shen Q, Sahir N (2011) The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 16(4):383–406. https://doi.org/10.1038/mp.2010.120
Madhoo M, Keefe RS, Roth RM, Sambunaris A, Wu J, Trivedi MH, Anderson CS, Lasser R (2014) Lisdexamfetamine dimesylate augmentation in adults with persistent executive dysfunction after partial or full remission of major depressive disorder. Neuropsychopharmacology 39(6):1388–1398. https://doi.org/10.1038/npp.2013.334
Maj M, Veltro F, Pirozzi R, Lobrace S, Magliano L (1992) Pattern of recurrence of illness after recovery from an episode of major depression: a prospective study. Am J Psychiatry 149(6):795–800. https://doi.org/10.1176/ajp.149.6.795
Maj M, Pirozzi R, Magliano L, Fiorillo A, Bartoli L (2006) Agitated “unipolar” major depression: prevalence, phenomenology, and outcome. J Clin Psychiatry 67(5):712–719
Mann JJ, Currier D (2007) A review of prospective studies of biologic predictors of suicidal behavior in mood disorders. Arch Suicide Res 11(1):3–16. https://doi.org/10.1080/13811110600993124
McCrae RR, Costa PT Jr (1987) Validation of the five-factor model of personality across instruments and observers. J Pers Soc Psychol 52(1):81–90
McCullough JP Jr, Klein DN, Keller MB, Holzer CE 3rd, Davis SM, Kornstein SG, Howland RH, Thase ME, Harrison WM (2000) Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction. J Abnorm Psychol 109(3):419–427
McCullough JP Jr, Klein DN, Borian FE, Howland RH, Riso LP, Keller MB, Banks PL (2003) Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, part 2. J Abnorm Psychol 112(4):614–622. https://doi.org/10.1037/0021-843X.112.4.614
McGrath PJ, Stewart JW, Harrison WM, Ocepek-Welikson K, Rabkin JG, Nunes EN, Wager SG, Tricamo E, Quitkin FM, Klein DF (1992) Predictive value of symptoms of atypical depression for differential drug treatment outcome. J Clin Psychopharmacol 12(3):197–202
Mercer D, Douglass AB, Links PS (2009) Meta-analyses of mood stabilizers, antidepressants and antipsychotics in the treatment of borderline personality disorder: effectiveness for depression and anger symptoms. J Personal Disord 23(2):156–174. https://doi.org/10.1521/pedi.2009.23.2.156
Miller HL, Delgado PL, Salomon RM, Berman R, Krystal JH, Heninger GR, Charney DS (1996) Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression. Arch Gen Psychiatry 53(2):117–128
Miller GE, Freedland KE, Carney RM, Stetler CA, Banks WA (2003) Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun 17(4):276–285
Mitchell AJ, Vaze A, Rao S (2009) Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374(9690):609–619. https://doi.org/10.1016/S0140-6736(09)60879-5
Mody I, Maguire J (2011) The reciprocal regulation of stress hormones and GABA(A) receptors. Front Cell Neurosci 6:4. https://doi.org/10.3389/fncel.2012.00004
Montgomery SA, Asberg M (1979) A new depression scale designed to be sensitive to change. Br J Psychiatry 134:382–389
Morrison JR (1973) Catatonia. Retarded and excited types. Arch Gen Psychiatry 28(1):39–41
Mortensen PB, Agerbo E, Erikson T, Qin P, Westergaard-Nielsen N (2000) Psychiatric illness and risk factors for suicide in Denmark. Lancet 355(9197):9–12
Muller N, Schwarz MJ, Dehning S, Douhe A, Cerovecki A, Goldstein-Muller B, Spellmann I, Hetzel G, Maino K, Kleindienst N, Moller HJ, Arolt V, Riedel M (2006) The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 11(7):680–684. https://doi.org/10.1038/sj.mp.4001805
Munkholm K, Vinberg M, Vedel Kessing L (2013) Cytokines in bipolar disorder: a systematic review and meta-analysis. J Affect Disord 144(1–2):16–27. https://doi.org/10.1016/j.jad.2012.06.010
Murphy JM, Horton NJ, Burke JD Jr, Monson RR, Laird NM, Lesage A, Sobol AM (2009) Obesity and weight gain in relation to depression: findings from the Stirling County study. Int J Obes 33(3):335–341. https://doi.org/10.1038/ijo.2008.273
Murphy-Eberenz K, Zandi PP, March D, Crowe RR, Scheftner WA, Alexander M, McInnis MG, Coryell W, Adams P, DePaulo JR Jr, Miller EB, Marta DH, Potash JB, Payne J, Levinson DF (2006) Is perinatal depression familial? J Affect Disord 90(1):49–55. https://doi.org/10.1016/j.jad.2005.10.006
Murrough JW, Soleimani L, DeWilde KE, Collins KA, Lapidus KA, Iacoviello BM, Lener M, Kautz M, Kim J, Stern JB, Price RB, Perez AM, Brallier JW, Rodriguez GJ, Goodman WK, Iosifescu DV, Charney DS (2015) Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial. Psychol Med 45(16):3571–3580. https://doi.org/10.1017/S0033291715001506
Naismith SL, Longley WA, Scott EM, Hickie IB (2007) Disability in major depression related to self-rated and objectively-measured cognitive deficits: a preliminary study. BMC Psychiatry 7:32
Nelson JC, Davis JM (1997) DST studies in psychotic depression: a meta-analysis. Am J Psychiatry 154(11):1497–1503. https://doi.org/10.1176/ajp.154.11.1497
Nelson JC, Bickford D, Delucchi K, Fiedorowicz JG, Coryell WH (2018) Risk of psychosis in recurrent episodes of psychotic and nonpsychotic major depressive disorder: a systematic review and meta-analysis. Am J Psychiatry 175(9):897–904. https://doi.org/10.1176/appi.ajp.2018.17101138
Nierenberg AA, DeCecco LM (2001) Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: a focus on treatment-resistant depression. J Clin Psychiatry 62(Suppl 16):5–9
Otto MW, Simon NM, Wisniewski SR, Miklowitz DJ, Kogan JN, Reilly-Harrington NA, Frank E, Nierenberg AA, Marangell LB, Sagduyu K, Weiss RD, Miyahara S, Thas ME, Sachs GS, Pollack MH, Investigators S-B (2006) Prospective 12-month course of bipolar disorder in out-patients with and without comorbid anxiety disorders. Br J Psychiatry 189:20–25. https://doi.org/10.1192/bjp.bp.104.007773
Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, Dording C, Fava M (2008) Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder. Psychiatry Res 161(1):116–120. https://doi.org/10.1016/j.psychres.2008.02.011
Paradiso S, Vaidya JG, McCormick LM, Jones A, Robinson RG (2008) Aging and alexithymia: association with reduced right rostral cingulate volume. Am J Geriatr Psychiatry 16(9):760–769. https://doi.org/10.1097/JGP.0b013e31817e73b0
Pennybaker SJ, Niciu MJ, Luckenbaugh DA, Zarate CA (2017) Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion. J Affect Disord 208:560–566. https://doi.org/10.1016/j.jad.2016.10.026
Perlis ML, Grandner MA, Brown GK, Basner M, Chakravorty S, Morales KH, Gehrman PR, Chaudhary NS, Thase ME, Dinges DF (2016) Nocturnal wakefulness as a previously unrecognized risk factor for suicide. J Clin Psychiatry 77(6):e726–e733. https://doi.org/10.4088/JCP.15m10131
Perris C (1966) A study of bipolar (manic-depressive) and unipolar recurrent depressive psychoses. I. Genetic investigation. Acta Psychiatr Scand Suppl 194:15–44
Persons JE, Coryell WH, Solomon DA, Keller MB, Endicott J, Fiedorowicz JG (2017) Mixed state and suicide: is the effect of mixed state on suicidal behavior more than the sum of its parts? Bipolar Disord. https://doi.org/10.1111/bdi.12538
Pfohl B, Stangl D, Zimmerman M (1984) The implications of DSM-III personality disorders for patients with major depression. J Affect Disord 7(3–4):309–318
Pintor L, Torres X, Navarro V, Matrai S, Gasto C (2004) Is the type of remission after a major depressive episode an important risk factor to relapses in a 4-year follow up? J Affect Disord 82(2):291–296. https://doi.org/10.1016/j.jad.2003.11.008
Prusoff BA, Klerman GL, Paykel ES (1972) Concordance between clinical assessments and patients’ self-report in depression. Arch Gen Psychiatry 26(6):546–552
Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, Haroon E, Miller AH (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat 70(1):31–41. https://doi.org/10.1001/2013.jamapsychiatry.4
Rasmussen SA, Mazurek MF, Rosebush PI (2016) Catatonia: our current understanding of its diagnosis, treatment and pathophysiology. World J Psychiatry 6(4):391
Reddy PL, Khanna S, Subhash MN, Channabasavanna SM, Rao BS (1992) CSF amine metabolites in depression. Biol Psychiatry 31(2):112–118
Rhebergen D, Beekman AT, Rd G, Nolen WA, Spijker J, Hoogendijk WJ, Penninx BW (2009) The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression. J Affect Disord 115(3):450–459. https://doi.org/10.1016/j.jad.2008.10.018
Rhebergen D, Beekman AT, de Graaf R, Nolen WA, Spijker J, Hoogendijk WJ, Penninx BW (2010) Trajectories of recovery of social and physical functioning in major depression, dysthymic disorder and double depression: a 3-year follow-up. J Affect Disord 124(1–2):148–156. https://doi.org/10.1016/j.jad.2009.10.029
Ruggero CJ, Kotov R, Carlson GA, Tanenberg-Karant M, Gonzalez DA, Bromet EJ (2011) Diagnostic consistency of major depression with psychosis across 10 years. J Clin Psychiatry 72(9):1207–1213. https://doi.org/10.4088/JCP.10m06774
Runeson B, Tidemalm D, Dahlin M, Lichtenstein P, Langstrom N (2010) Method of attempted suicide as predictor of subsequent successful suicide: national long term cohort study. BMJ 341:c3222. https://doi.org/10.1136/bmj.c3222
Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C (1986) The inventory for depressive symptomatology (IDS): preliminary findings. Psychiatry Res 18(1):65–87
Rush AJ, Gullion CM, Basco MR, Jarrett RB, Trivedi MH (1996) The inventory of depressive symptomatology (IDS): psychometric properties. Psychol Med 26(3):477–486
Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF, Force AT (2006) Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacology 31(9):1841–1853. https://doi.org/10.1038/sj.npp.1301131
Salagre E, Sole B, Tomioka Y, Fernandes BS, Hidalgo-Mazzei D, Garriga M, Jimenez E, Sanchez-Moreno J, Vieta E, Grande I (2017) Treatment of neurocognitive symptoms in unipolar depression: a systematic review and future perspectives. J Affect Disord 221:205–221. https://doi.org/10.1016/j.jad.2017.06.034
Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH (1999) Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56(11):1043–1047
Sanacora G, Gueorguieva R, Epperson CN, Wu YT, Appel M, Rothman DL, Krystal JH, Mason GF (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61(7):705–713. https://doi.org/10.1001/archpsyc.61.7.705
Sarchiapone M, Carli V, Camardese G, Cuomo C, Di Giuda D, Calcagni ML, Focacci C, De Risio S (2006) Dopamine transporter binding in depressed patients with anhedonia. Psychiatry Res 147(2–3):243–248. https://doi.org/10.1016/j.pscychresns.2006.03.001
Sareen J, Cox BJ, Afifi TO, de Graaf R, Asmundson GJ, ten Have M, Stein MB (2005) Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults. Arch Gen Psychiatry 62(11):1249–1257. https://doi.org/10.1001/archpsyc.62.11.1249
Schildkraut JJ (1965) The catecholamine hypothesis of affective disorders: a review of supporting evidence. Am J Psychiatry 122(5):509–522
Schildkraut JJ (1967) The catecholamine hypothesis of affective disorders. A review of supporting evidence. Int J Psychiatry 4(3):203–217
Schlesser MA, Winokur G, Sherman BM (1980) Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification. Arch Gen Psychiatry 37(7):737–743
Schuckit MA (1994) Low level of response to alcohol as a predictor of future alcoholism. Am J Psychiatry 151(2):184–189. https://doi.org/10.1176/ajp.151.2.184
Shea MT, Pilkonis PA, Beckham E, Collins JF, Elkin I, Sotsky SM, Docherty JP (1990) Personality disorders and treatment outcome in the NIMH Treatment of Depression Collaborative Research Program. Am J Psychiatry 147(6):711–718. https://doi.org/10.1176/ajp.147.6.711
Shepard DS, Gurewich D, Lwin AK, Reed GA Jr, Silverman MM (2016) Suicide and suicidal attempts in the United States: costs and policy implications. Suicide Life Threat Behav 46(3):352–362. https://doi.org/10.1111/sltb.12225
Shors TJ, Seib TB, Levine S, Thompson RF (1989) Inescapable versus escapable shock modulates long-term potentiation in the rat hippocampus. Science 244(4901):224–226
Shorter E (2007) The doctrine of the two depressions in historical perspective. Acta Psychiatr Scand Suppl 433:5–13. https://doi.org/10.1111/j.1600-0447.2007.00957.x
Simon GE, VonKorff M (1995) Recall of psychiatric history in cross-sectional surveys: implications for epidemiologic research. Epidemiol Rev 17(1):221–227
Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, Van Nueten L (2016) A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in patients with treatment-resistant depression. Am J Psychiatry 173(8):816–826. https://doi.org/10.1176/appi.ajp.2016.16010037
Spitzer RL, Endicott J, Robins E (1978) Research diagnostic criteria: rationale and reliability. Arch Gen Psychiatry 35(6):773–782
Szmulewicz AG, Angriman F, Samame C, Ferraris A, Vigo D, Strejilevich SA (2017) Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis. Acta Psychiatr Scand 135(6):527–538. https://doi.org/10.1111/acps.12712
Taylor MA, Fink M (2008) Restoring melancholia in the classification of mood disorders. J Affect Disord 105(1–3):1–14. https://doi.org/10.1016/j.jad.2007.05.023
Thamizh JS, Harshini M, Selvakumar N, Bharadwaj B, Menon V (2016) Maintenance lorazepam for treatment of recurrent catatonic states: a case series and implications. Asian J Psychiatr 22:147–149. https://doi.org/10.1016/j.ajp.2016.06.002
Thase ME, Friedman ES (1999) Is psychotherapy an effective treatment for melancholia and other severe depressive states? J Affect Disord 54(1–2):1–19
Trullas R, Skolnick P (1990) Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur J Pharmacol 185(1):1–10
Ustun TB, Ayuso-Mateos JL, Chatterji S, Mathers C, Murray CJ (2004) Global burden of depressive disorders in the year 2000. Br J Psychiatry 184:386–392
Vande Voort JL, Morgan RJ, Kung S, Rasmussen KG, Rico J, Palmer BA, Schak KM, Tye SJ, Ritter MJ, Frye MA, Bobo WV (2016) Continuation phase intravenous ketamine in adults with treatment-resistant depression. J Affect Disord 206:300–304. https://doi.org/10.1016/j.jad.2016.09.008
Vesga-Lopez O, Blanco C, Keyes K, Olfson M, Grant BF, Hasin DS (2008) Psychiatric disorders in pregnant and postpartum women in the United States. Arch Gen Psychiatry 65(7):805–815. https://doi.org/10.1001/archpsyc.65.7.805
Vinckier F, Gourion D, Mouchabac S (2017) Anhedonia predicts poor psychosocial functioning: results from a large cohort of patients treated for major depressive disorder by general practitioners. Eur Psychiatry 44:1–8. https://doi.org/10.1016/j.eurpsy.2017.02.485
Vogelzangs N, Beekman AT, van Reedt Dortland AK, Schoevers RA, Giltay EJ, de Jonge P, Penninx BW (2014) Inflammatory and metabolic dysregulation and the 2-year course of depressive disorders in antidepressant users. Neuropsychopharmacology 39(7):1624–1634. https://doi.org/10.1038/npp.2014.9
Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen H, Yeh EK (1996) Cross-national epidemiology of major depression and bipolar disorder. JAMA 276(4):293–299
Winokur G, Clayton PJ, Reich T (1969) Manic depressive illness. C. V. Mosby, St. Louis 186 pp
Yang T, Dunner DL (2001) Differential subtyping of depression. Depress Anxiety 13(1):11–17
Yoshimasu K, Kiyohara C, Miyashita K, Stress Research Group of the Japanese Society for H (2008) Suicidal risk factors and completed suicide: meta-analyses based on psychological autopsy studies. Environ Health Prev Med 13(5):243–256. https://doi.org/10.1007/s12199-008-0037-x
Zahn R, Lythe KE, Gethin JA, Green S, Deakin JF, Young AH, Moll J (2015) The role of self-blame and worthlessness in the psychopathology of major depressive disorder. J Affect Disord 186:337–341. https://doi.org/10.1016/j.jad.2015.08.001
Zimmerman M, Coryell W, Pfohl B, Corenthal C, Stangl D (1986) ECT response in depressed patients with and without a DSM-III personality disorder. Am J Psychiatry 143(8):1030–1032. https://doi.org/10.1176/ajp.143.8.1030
Zimmerman M, Galione JN, Ruggero CJ, Chelminski I, Dalrymple K, Young D (2010) Overdiagnosis of bipolar disorder and disability payments. J Nerv Ment Dis 198(6):452–454. https://doi.org/10.1097/NMD.0b013e3181e084e1
Zimmermann P, Bruckl T, Nocon A, Pfister H, Lieb R, Wittchen HU, Holsboer F, Angst J (2009) Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 66(12):1341–1352. https://doi.org/10.1001/archgenpsychiatry.2009.158
Zisook S, Pies R, Iglewicz A (2013) Grief, depression, and the DSM-5. J Psychiatr Pract 19(5):386–396. https://doi.org/10.1097/01.pra.0000435037.91049.2f
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Coryell, W. (2018). Impact, Diagnosis, Phenomenology, and Biology. In: Macaluso, M., Preskorn, S. (eds) Antidepressants. Handbook of Experimental Pharmacology, vol 250. Springer, Cham. https://doi.org/10.1007/164_2018_156
Download citation
DOI: https://doi.org/10.1007/164_2018_156
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-10948-6
Online ISBN: 978-3-030-10949-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)